ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY
LIVE

Serial Number

76635438

Owner

Associated Regional and University Pathologists, Inc.

Attorney

Lester K. Essig

First Use Date

Mar 1, 2000

Filing Date

Apr 8, 2005

Add to watchlist:

No watchlists yet
View on USPTO

ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY Trademark

Serial Number: 76635438 • Registration: 3315105

ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY is a trademark filed by Associated Regional and University Pathologists, Inc. on April 8, 2005. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Associated Regional and University Pathologists, Inc.

500 Chipeta Way
Salt Lake City, UT 84108

Entity Type: 03

ARUP LABORATORIES, INC. (27 trademarks)

500 CHIPETA WAY
SALT LAKE CITY, UT 84108

Entity Type: 03

Trademark Details

Filing Date

April 8, 2005

Registration Date

October 23, 2007

First Use Anywhere

March 1, 2000

First Use in Commerce

March 1, 2000

Published for Opposition

August 7, 2007

Goods & Services

Clinical laboratory services, reference laboratory services, diagnostic laboratory services, medical laboratory services, and providing medical laboratory information online over the global communications network, all in the fields of pathology, clinical pathology, anatomic pathology, histopathology, histology, infectious diseases, disease pathology, infectious disease pathology, staining analysis, virology, hematopathology, hematology, proteomics, hemostasis, thrombosis, flow analysis, flow cytometry, capillary electrophoresis, genetics, molecular genetics, biochemical genetics, genetic diseases, gene identification, gene sequencing, nucleotide sequencing, genotypic identification, phenotypic identification, probe synthesis, gene therapy, mass spectrometry, tandem mass spectrometry, molecular testing, molecular diagnostics, molecular evaluation, cytopathology, cytology, cytogenetics, oncology, tumor detection, tumor markers, tumor diagnostics, mutation detection, mutation analysis, morphologic change, immunopathology, immunology, immunohematology, immunohistochemical staining, inununofluorescence, autoimmune disorders, microbiology, serology, microbial serology, endocrinology, clinical chemistry, toxicology, clinical toxicology, toxins, pharmacogenomics, therapeutic drugs, transplantation pathology, surgical pathology, autopsy pathology, metabolics, metabolic status, nutritional status, microscopy, core lab testing, engineering analysis, laboratory automation, medical informatics, and health care; clinical laboratory services, reference laboratory services, dissection laboratory services, diagnostic laboratory services, medical laboratory services, veterinary laboratory services, and medical and scientific research, namely, collecting, processing, treating, freezing, staining, dissecting, analyzing, screening, testing, typing and storing of biological substances and human and animal tissue, blood, blood components, cells, stems cells, abnormal cells, chromosomes and nucleic acid; development, improvement, evaluation, analysis and application of clinical laboratory tests and diagnostics in the fields of pathology, clinical pathology, anatomic pathology, histopathology, histology, infectious diseases, disease pathology, infectious disease pathology, staining analysis, virology, hematopathology, hematology, proteomics, hemostasis, thrombosis, flow analysis, flow cytometry, capillary electrophoresis, genetics, molecular genetics, biochemical genetics, genetic diseases, gene identification, gene sequencing, nucleotide sequencing, genotypic identification, phenotypic identification, probe synthesis, mass spectrometry, tandem mass spectrometry, molecular testing, molecular diagnostics, molecular evaluation, cytopathology, cytology, cytogenetics, oncology, tumor detection, tumor markers, tumor diagnostics, mutation detection, mutation analysis, morphologic change, immunopathology, immunology, immunohematology, immunohistochemical staining, immunofluorescence, autoimmune disorders, microbiology, serology, microbial serology, endocrinology, clinical chemistry, toxicology, clinical toxicology, toxins, pharmacogenomics, therapeutic drugs, transplantation pathology, surgical pathology, autopsy pathology, metabolics, metabolic status, nutritional status, microscopy, core lab testing, engineering analysis, laboratory automation, medical informatics, and health care; and medical research in the fields of pathology, clinical pathology, anatomic pathology, histopathology, histology, infectious diseases, disease pathology, infectious disease pathology, staining analysis, virology, hematopathology, hematology, proteomics, hemostasis, thrombosis, flow analysis, flow cytometry, capillary electrophoresis, genetics, molecular genetics, biochemical genetics, genetic diseases, gene identification, gene sequencing, nucleotide sequencing, genotypic identification, phenotypic identification, probe synthesis, mass spectrometry, tandem mass spectrometry, molecular testing, molecular diagnostics, molecular evaluation, cytopathology, cytology, cytogenetics, oncology, tumor detection, tumor markers, tumor diagnostics, mutation detection, mutation analysis, morphologic change, immunopathology, immunology, immunohematology, immunohistochemical staining, immunofluorescence, autoimmune disorders, microbiology, serology, microbial serology, endocrinology, clinical chemistry, toxicology, clinical toxicology, toxins, pharmacogenomics, therapeutic drugs, transplantation pathology, surgical pathology, autopsy pathology, metabolics, metabolic status, nutritional status, microscopy, core lab testing, engineering analysis, laboratory automation, medical informatics, and health care

Medical testing services in the fields of pathology, clinical pathology, anatomic pathology, histopathology, histology, infectious diseases, disease pathology, infectious disease pathology, staining analysis, virology, hematopathology, hematology, proteomics, hemostasis, thrombosis, flow analysis, flow cytometry, capillary electrophoresis, genetics, molecular genetics, biochemical genetics, genetic diseases, gene identification, gene sequencing, nucleotide sequencing, genotypic identification, phenotypic identification, probe synthesis, mass spectrometry, tandem mass spectrometry, molecular testing, molecular diagnostics, molecular evaluation, cytopathology, cytology, cytogenetics, oncology, tumor detection, tumor markers, tumor diagnostics, mutation detection, mutation analysis, morphologic change, immunopathology, immunology, immunohematology, immunohistochemical staining, immunofluorescence, autoimmune disorders, microbiology, serology, microbial serology, endocrinology, clinical chemistry, toxicology, clinical toxicology, toxins, pharmacogenomics, therapeutic drugs, transplantation pathology, surgical pathology, autopsy pathology, metabolics, metabolic status, nutritional status, microscopy, core lab testing, engineering analysis, laboratory automation, medical informatics, and health care; and providing medical information online over a global communications network in the fields of pathology, clinical pathology, anatomic pathology, histopathology, histology, infectious diseases, disease pathology, infectious disease pathology, staining analysis, virology, hematopathology, hematology, proteomics, hemostasis, thrombosis, flow analysis, flow cytometry, capillary electrophoresis, genetics, molecular genetics, biochemical genetics, genetic diseases, gene identification, gene sequencing, nucleotide sequencing, genotypic identification, phenotypic identification, probe synthesis, mass spectrometry, tandem mass spectrometry, molecular testing, molecular diagnostics, molecular evaluation, cytopathology, cytology, cytogenetics, oncology, tumor detection, tumor markers, tumor diagnostics, mutation detection, mutation analysis, morphologic change, immunopatho logy, immunology, immunohematology, immunohistochemical staining, immunofluorescence, autoimmune disorders, microbiology, serology, microbial serology, endocrinology, clinical chemistry, toxicology, clinical toxicology, toxins, pharmacogenomics, therapeutic drugs, transplantation pathology, surgical pathology, autopsy pathology, metabolics, metabolic status, nutritional status, microscopy, core lab testing, engineering analysis, laboratory automation, medical informatics, and health care

Filing History

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Apr 28, 2026 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 28, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 28, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 28, 2026 REAP
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - MAILED
Nov 18, 2017 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Nov 18, 2017 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Nov 18, 2017 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 18, 2017 APRE
TEAS SECTION 8 & 9 RECEIVED
Oct 23, 2017 E89R
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - MAILED
Feb 5, 2014 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Feb 4, 2014 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 4, 2014 APRE
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Jan 23, 2014 815F
PAPER RECEIVED
Jan 23, 2014 MAIL
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 20, 2013 ASGN
REGISTERED-PRINCIPAL REGISTER
Oct 23, 2007 R.PR
PUBLISHED FOR OPPOSITION
Aug 7, 2007 PUBO
NOTICE OF PUBLICATION
Jul 18, 2007 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 5, 2007 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 22, 2007 CNSA
EXAMINERS AMENDMENT MAILED
Jun 7, 2007 CNEA
EXAMINER'S AMENDMENT ENTERED
Jun 7, 2007 XAEC
EXAMINERS AMENDMENT -WRITTEN
Jun 7, 2007 CNEA
AMENDMENT FROM APPLICANT ENTERED
May 16, 2007 ACEC
ASSIGNED TO LIE
May 16, 2007 ALIE
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 25, 2007 CRFA
PAPER RECEIVED
Apr 25, 2007 MAIL
FINAL REFUSAL MAILED
Nov 3, 2006 CNFR
FINAL REFUSAL WRITTEN
Nov 3, 2006 CNFR
AMENDMENT FROM APPLICANT ENTERED
Oct 12, 2006 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 25, 2006 CRFA
PAPER RECEIVED
Sep 25, 2006 MAIL
NON-FINAL ACTION MAILED
Mar 24, 2006 CNRT
NON-FINAL ACTION WRITTEN
Mar 24, 2006 CNRT
NON-FINAL ACTION MAILED
Nov 9, 2005 CNRT
NON-FINAL ACTION WRITTEN
Nov 8, 2005 CNRT
ASSIGNED TO EXAMINER
Nov 7, 2005 DOCK
NEW APPLICATION ENTERED
Apr 20, 2005 NWAP